DISCOVER-2:
Guselkumab in bionaïve PsA
Work productivity data at 2 yrs
64% employed at BL; 50% work impairment at BL
84% employed at BL continued to work
Amongst unemployed at BL proportion of pts working rose by >=20%
t.co/zqmfFvPPMi
Abst #0509 #ACR22 @Rheumnow
Guselkumab Provides Sustained Improvements in Work Productivity and Daily Activity in Patients with Active Psoriatic Arthritis Through 2 Years of DISCOVER-2 - ACR Meeting Abstracts
Guselkumab in bionaïve PsA
Work productivity data at 2 yrs
64% employed at BL; 50% work impairment at BL
84% employed at BL continued to work
Amongst unemployed at BL proportion of pts working rose by >=20%
t.co/zqmfFvPPMi
Abst #0509 #ACR22 @Rheumnow
